丙种球蛋白治疗早产儿呼吸机相关性肺炎疗效观察  

Immunoglobulin for treating ventilator-associated pneumonia of premature infants

作　　者：杨琳琳[1] 陈运彬[1] 杨杰[1] 张永[1] 黄东平[1] 刘桂霞[2] 

机构地区：[1]广东省妇幼保健院,510010 [2]吉林省妇幼保健院

出　　处：《中国妇幼保健》2003年第9期550-551,共2页Maternal and Child Health Care of China

摘　　要：探讨静脉丙种球蛋白治疗早产儿呼吸机相关性肺炎的疗效 ,采用随机对照的方法 ,将 110例确诊为呼吸机相关性肺炎的早产儿分为两组。对其中 5 4例患儿给予静脉滴注丙种球蛋白 4 0 0 m g/ kg/ d,连用 3d。结果显示 ,加用丙种球蛋白的治疗组患儿死亡率为 2 3.2 % ,对照组为 39.9%。统计学分析χ2 =4 .0 7,P<0 .0 5 ,有显著性意义。MCH hospital of Guangdong province To study the effect of immunoglobulin treatment of premature with ventilator associated pneumonia. 110 cases were divided and compared for analysis into two group, 54 in treatment by immunoglobulin 400 mg/kg.d within three days and 56 in control group were 23.2% and 39.9%. χ 2 =4.07, P <0.05. There were significant difference respectively . It is suggested that IVIG has satisfactory therapeutic effectiveness for treating ventilator associated pneumonia of premature infants.

关 键 词：丙种球蛋白 治疗 早产儿 呼吸机相关性肺炎 疗效观察 

分 类 号：R722.135[医药卫生—儿科]